MGRC’s corporate DNA


Sasha: ‘We realised that no one has taken the opportunity to develop the pathology industry in Malaysia, in terms of technology, and we want to be the ones to do that.’

Malaysian Genomics may be off investors’ radar, but hopes awareness of pathology will increase

SINCE its listing on the Ace Market of Bursa Malaysia back in 2010, Malaysian Genomics Resource Centre Bhd (MGRC) seems to have fallen off the radar of investors.

Article type: metered
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights
   

Next In Business News

Oil falls on uncertainty over fuel demand recovery Premium
Asian shares bounce as China moves to boost housing Premium
IMF urges Asia to be mindful of spillover risks from tightening Premium
Shanghai economy hit on all sides in April by Covid lockdown Premium
Sime Darby Plantation's 1Q net profit lifted to RM718mil on higher CPO, PK prices Premium
Pharmaniaga posts net profit of RM27.72mil in 1Q, declares 0.8 sen div Premium
FBM KLCI stays positive amid volatility in plantations stocks Premium
MPIC in the midst of discussions with MoF to slash palm oil export tax Premium
Khazanah partners SK ecoplant to help grow waste management services unit Premium
Ringgit rebounds against US$ at opening Premium

Others Also Read